Monday, November 10, 2025
HomeIndustriesBiotechnology

Biotechnology

Triumvira Immunologics Announces First Patient Dosed in Phase II of TACTIC-2 Cell Therapy Trial for the Treatment of HER2+ Gastric and GEJ Cancers

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat...

Read Magazine’s Weekly Roundup: Discover the Most Recent News From Opus IVS, Roche, Ever.Ag, NuStar Energy, Icertis, Mouser Electronics!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders

Triveni Bio Inc., a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders, announced a...

Kemin Biologics Partners with ilender to Launch MEFLUVAC™ H5 PLUS 8 Vaccine to Empower the Peruvian Poultry Industry Against Avian Influenza

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with...

BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023

BioLife Solutions, Inc., a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, announced...
0FansLike
0FollowersFollow
spot_img

Hot Topics